Trading
Search documents
CLASS ACTION REMINDER: Berger Montague Advises Marex Group PLC (NASDAQ: MRX) Investors to Inquire About a Securities Fraud Lawsuit by December 8, 2025
Prnewswire· 2025-11-24 13:21
Core Viewpoint - A class action lawsuit has been filed against Marex Group plc due to allegations of financial improprieties, including a multi-year accounting scheme that concealed losses and inflated profits [1][3][4]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased Marex shares from May 16, 2024, to August 5, 2025 [1][2]. - Investors have until December 8, 2025, to seek appointment as lead plaintiff [2]. Group 2: Allegations Against Marex - NINGI Research reported that Marex engaged in a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions [3]. - The report highlighted discrepancies in intercompany receivables and loans across over 56 entities, amounting to multi-million-dollar differences [3]. - Marex allegedly concealed nearly $1 billion in off-balance-sheet derivatives, inflating operating cash flow by misclassifying structured note issuance as income [4]. Group 3: Market Reaction - Following the release of the report, Marex's stock price fell by $2.33, or 6.2%, closing at $35.31, resulting in significant investor losses [4].
SHAREHOLDER ALERT: Berger Montague Reminds Marex Group plc (NASDAQ: MRX) Investors of Class Action Lawsuit Deadline
Prnewswire· 2025-11-17 14:06
Core Points - A class action lawsuit has been filed against Marex Group plc on behalf of investors who purchased shares between May 16, 2024, and August 5, 2025 [1][2] - The lawsuit alleges that Marex concealed losses and inflated profits through off-balance-sheet entities and fictitious transactions, leading to a significant drop in stock price [3] Company Overview - Marex Group plc is a London-based global financial services company specializing in trading, clearing, and risk management [2] Legal Context - Investors have until December 8, 2025, to seek appointment as lead plaintiff in the class action [2] - The lawsuit was triggered by a report from NINGI Research published on August 5, 2025, which accused Marex of financial misconduct [3]
iFAST vs SGX: Which Growth Stock Could Deliver Better Returns in 2026?
The Smart Investor· 2025-11-17 09:30
Core Insights - The article compares two growth stocks in Singapore: iFAST Corporation, a fintech platform, and Singapore Exchange (SGX), a blue-chip exchange operator, highlighting their growth potential and market positions as interest rates are expected to fall by 2026 [1][8]. iFAST Corporation - iFAST has transitioned from a fund distribution platform to a digital wealth infrastructure player, achieving a net revenue growth of 39.9% year-on-year to S$89.53 million and a net profit increase of 54.7% year-on-year to S$26 million for 3Q 2025 [2]. - The company's assets under administration (AUA) reached an all-time high of S$30.62 billion, growing 29.6% year-on-year [2]. - iFAST's profit before tax margin improved to 34.5% for 9M 2025, up from 22.6% in 2023 and 33.5% in 2024, indicating a new phase of profitability [3]. - Recent initiatives include the introduction of payment services and the approval to operate as an Electronic Money Issuer in Malaysia, which could enhance profitability [4]. Singapore Exchange (SGX) - SGX serves as the backbone of Singapore's capital markets, with a revenue breakdown showing that the Equities-Cash segment contributed 30.3% and the Equities-Derivatives segment contributed 26.6% to total net revenue for FY25 [5]. - SGX's net profit attributable to equity holders grew from S$445 million in FY2021 to S$648 million in FY2025, with dividends increasing from S$0.32 to S$0.375 during the same period [6]. - Recent partnerships, such as with Climate Impact X, and expansion in Foreign Exchange derivatives are expected to drive growth [7]. Comparative Analysis - iFAST offers higher growth potential with a revenue growth rate of 29.5% CAGR over three years, while SGX has a more stable growth rate of 7.6% [9]. - iFAST has a profit margin of 18.5% compared to SGX's 47.3%, and a lower dividend yield of 0.7% versus SGX's 2.2% [9]. - The choice between iFAST and SGX depends on investor preferences for growth acceleration versus stable compounding [10]. Key Catalysts and Risks - For iFAST, successful digital platform rollouts and margin expansion are potential growth drivers, while delays or contract risks could negatively impact valuation [11]. - SGX's growth will depend on market turnover and derivatives volume recovery, with lower volatility potentially limiting momentum [11]. - Both companies could benefit from macro trends such as rate cuts and improved investor sentiment [12]. Investor Considerations - Investors should monitor earnings growth and dividend policies for both companies through 2025, as well as valuation movements post-rate cuts [13][14]. - A diversified investment approach could involve holding both stocks to balance growth and stability [15].
INVESTOR REMINDER: Berger Montague Notifies Marex Group plc Investors (NASDAQ: MRX) of a Class Action Lawsuit and Deadline
Prnewswire· 2025-11-10 20:07
Core Viewpoint - A class action lawsuit has been filed against Marex Group plc, alleging significant accounting irregularities and misleading disclosures that resulted in inflated profits and concealed losses [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased Marex shares between May 16, 2024, and August 5, 2025 [1][2]. - Investors have until December 8, 2025, to seek appointment as lead plaintiff [2]. - The lawsuit follows a report from NINGI Research that accused Marex of engaging in a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions [3][4]. Group 2: Allegations and Financial Discrepancies - The report highlighted multi-million-dollar discrepancies in intercompany receivables and loans, including a fabricated $17 million receivable and a subsidiary's profits inflated by 150% [4]. - It was alleged that Marex concealed nearly $1 billion in off-balance-sheet derivatives exposure, which was used to generate non-cash trading profits [4]. Group 3: Market Reaction - Following the report's release, Marex's stock price dropped by $2.33, or 6.2%, closing at $35.31, indicating significant investor losses [5].
X @Mayne
Mayne· 2025-11-03 18:48
RT Breakout (@breakoutprop)Derek got a $3,800 payout approved in 15 minutes.He didn’t need to wait to continue trading, because we adjust your balance immediately.Sahib got 3 payouts in one trading session.Because Breakout has on-demand payouts with no consistency rule.Traders are cooking 👨🍳 https://t.co/IS0PXt73kY ...
NASDAQ: MRX INVESTOR ALERT: Berger Montague Advises Marex Group plc (NASDAQ: MRX) Investors of a December 8, 2025 Deadline
Prnewswire· 2025-11-03 14:06
Core Points - A class action lawsuit has been filed against Marex Group plc on behalf of investors who purchased shares between May 16, 2024, and August 5, 2025 [1][2] - The lawsuit follows a report by NINGI Research that alleged financial improprieties, including a multi-year accounting scheme and misleading disclosures [3][4] - Marex is accused of concealing nearly $1 billion in off-balance-sheet derivatives, which inflated profits and operating cash flow [4] Company Overview - Marex Group plc is headquartered in London and provides global financial services, including trading, clearing, and risk management [2] Allegations and Impact - The complaint details discrepancies in intercompany receivables and loans across over 56 entities, amounting to multi-million-dollar discrepancies [3] - Following the release of the report, Marex's stock price fell by $2.33, or 6.2%, closing at $35.31, resulting in significant investor losses [4]
Cboe Global Markets Declares Fourth-Quarter 2025 Dividend
Prnewswire· 2025-10-23 20:34
Core Points - Cboe Global Markets has declared a quarterly cash dividend of $0.72 per share for the fourth quarter of 2025, payable on December 15, 2025, to stockholders of record as of November 28, 2025 [1] Company Overview - Cboe Global Markets is recognized as the world's leading derivatives and securities exchange network, providing advanced trading, clearing, and investment solutions globally [2] - The company offers trading solutions across multiple asset classes, including equities, derivatives, and foreign exchange, in regions such as North America, Europe, and Asia Pacific [2] - Cboe is dedicated to creating a trusted and inclusive global marketplace that supports sustainable financial futures for its users [2]